BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31632026)

  • 21. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immunity induced by recombinant protein CPSIT_p8 of Chlamydia psittaci.
    Liang M; Wen Y; Ran O; Chen L; Wang C; Li L; Xie Y; Zhang Y; Chen C; Wu Y
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6385-6393. PubMed ID: 27052378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
    Wu H; Bao Y; Wang X; Zhou D; Wu W
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28129034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.
    Sabbaghi A; Zargar M; Zolfaghari MR; Motamedi-Sedeh F; Ghaemi A
    Arch Virol; 2021 Feb; 166(2):545-557. PubMed ID: 33409549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal immunization with a rNMB0315 and combination adjuvants induces protective immunity against Neisseria meningitidis serogroup B in mice.
    Li Z; Li Y; Wang Y; Hou Y; Cao H; Wu X; Hu S; Long D
    Int Immunopharmacol; 2021 Apr; 93():107411. PubMed ID: 33548582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Intranasal Vaccine With PmpGs + MOMP Induces Robust Protections Both in Respiratory Tract and Genital System Posting
    Li Q; Chen S; Yan Z; Fang H; Wang Z; He C
    Front Vet Sci; 2022; 9():855447. PubMed ID: 35529835
    [No Abstract]   [Full Text] [Related]  

  • 29. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
    Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
    J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal immunity in mice induced by orally administered transgenic rice.
    Zhang X; Yuan Z; Duan Q; Zhu H; Yu H; Wang Q
    Vaccine; 2009 Mar; 27(10):1596-600. PubMed ID: 19146896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
    Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.
    Bode J; Dutow P; Sommer K; Janik K; Glage S; Tümmler B; Munder A; Laudeley R; Sachse KW; Klos A
    PLoS One; 2012; 7(11):e50327. PubMed ID: 23189195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curdlan sulfate-
    Zhang S; Huang S; Lu L; Song X; Li P; Wang F
    Int J Nanomedicine; 2018; 13():2377-2394. PubMed ID: 29713168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
    Dabaghian M; Latifi AM; Tebianian M; NajmiNejad H; Ebrahimi SM
    Vaccine; 2018 May; 36(20):2886-2895. PubMed ID: 29627234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.
    Todoroff J; Lemaire MM; Fillee C; Jurion F; Renauld JC; Huygen K; Vanbever R
    PLoS One; 2013; 8(5):e63344. PubMed ID: 23675482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
    Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
    Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal immunization with O-2'-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens.
    Zhao K; Sun B; Shi C; Sun Y; Jin Z; Hu G
    J Nanobiotechnology; 2021 Aug; 19(1):240. PubMed ID: 34380522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein.
    Vanrompay D; Cox E; Volckaert G; Goddeeris B
    Clin Exp Immunol; 1999 Oct; 118(1):49-55. PubMed ID: 10540159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK; Aldwell FE; Beagley KW
    Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
    Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.